Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0001193125-26-279723

Options or other derivatives

  • Director acquired 64,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Berman Howard Director 2026-06-18 Grant or award · Restricted Stock Units +26,700 26,700 D: show line 1 in the form
Berman Howard Director 2026-06-18 Grant or award · Stock Option (Right to Buy) +37,700 37,700 D: show line 2 in the form
Loading xslF345X06/ownership.xml…